We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Cord Blood America Secures $200,000 for Potential Acquisition

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Cord Blood America Secures $200,000 for Potential Acquisition"

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Read time:

Cord Blood America, Inc. has announced that it has secured $200,000 in capital which will allow it to complete a potential acquisition for which a Letter of Intent has been issued. The money is provided by a leading institutional investment firm from New York City.

"The funding is a debt placement, which we chose for similar reasons to our previous debt placements. Most importantly, it minimizes dilution, protecting our current shareholders," said Matthew Schissler, CEO, Cord Blood America.

"We are a growth-oriented company and there will be times when we need to raise capital using equity. Once again, this was not one of those times. This transaction protects that option for the Company and its shareholders," he continued.

The debt will be serviced primarily with cash flow from the still to be named acquisition.

Mr. Schissler said completion of the debt placement prior to completing the acquisition is "extremely important to principals of selling companies." He explained that CBAI can continue to attract new acquisitions because of the Company's ability to secure capital prior to closing.

"It's easier to make acquisitions when you have the financing already secured," Mr. Schissler said.